Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
News

Doctors need education on prescribing opioids

Steve Mertl
CMAJ October 04, 2016 188 (14) 1003; DOI: https://doi.org/10.1503/cmaj.109-5322
Steve Mertl
Vancouver, BC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

The Canadian Medical Protective Association (CMPA) is committed to curbing practices that have led to the opioid abuse crisis. That crisis is largely due to a spike in opioid overdose deaths connected with the street trade in drugs such as fentanyl. But prescribing practices are also implicated.

“I think it is on everybody’s radar right now.” said Dr. Gordon Wallace, managing director for safe medical care for CMPA, a not-for-profit medical mutual defence organization. All physicians want to find the “sweet spot” for pain relief without adverse risks, but need more education and support, he added

Doctors write 53 opioid prescriptions for every 100 people in Canada, according to numbers compiled for The Globe and Mail by IMS Brogan, which tracks pharmaceutical sales. The Globe reports that there are an estimated 2000 opioid-related deaths in Canada annually.

Physicians must fundamentally change their approach to when opioids should be prescribed, in what dose and for how long, a panel of experts told the CMPA’s annual meeting Aug. 24.

Attendees heard of the case of a 14-year-old boy with infectious mononucleosis who was prescribed fentanyl via transdermal patch to relieve difficulty in swallowing due to a sore throat. The pharmacist questioned the 25 μg/hour dosage but did not call the doctor, instead advising the mother to monitor her child closely. She did until the boy went to sleep. The next morning, he could not be revived. The coroner ruled the cause of death was respiratory arrest secondary to fentanyl use.

Professional recognition of the crisis is long overdue, Wallace said in an interview. The CMPA stepped up its involvement following a study of 151 opioid-related, medical-legal cases it handled between 2010 and 2015.

The CMPA would not provide information on the costs of liability payouts or physician sanctions from the reviewed files, but spokeswoman Isabelle Des Chênes said there were generally more unfavourable outcomes for doctors in opioid complaints than in other CMPA cases.

The 151 civil suits and complaints to professional colleges and hospitals revealed three main areas of concern, Wallace said.

Figure

Doctors write 53 opioid prescriptions for every 100 people in Canada.

Image courtesy of Marjan_Apostolovic/iStock

First were shortcomings in assessing when opioids should be prescribed. Canada ranks second only to the United States in per capita opioid consumption, far ahead of Europe and Australia/New Zealand.

The second problem involved doctors prescribing opioids with other drugs, particularly benzodiazepines, exacerbating the risk of respiratory failure.

The third issue is the challenge doctors have in identifying drug-seeking patients who don’t have medical conditions that justify opioid use. There needs to be better communication among pharmacists and prescribers to counter these requests, said Wallace.

British Columbia’s PharmaNet database was held up as a model for tackling abuse. It records all patient prescriptions, making it easier to flag patients “shopping” for prescriptions and so-called “refill slippage,” when patients claim they have lost their pills or need more because they’re leaving on a trip.

The number of opioid-related complaints in the study was fairly uniform year over year, Wallace said. “But...I think we’re going to see more.”

The CMPA issued two publications on opioids this year; one outlining the scope of the problem and a guide to prescribing opioids for non-cancer chronic pain. A third, due this fall, is aimed at hospital practitioners.

The opioid crisis is “the worst man-made epidemic in modern medical history,” University of Washington research professor Dr. Gary Franklin told attendees at the CMPA session.

When long-acting opioids were introduced two decades ago, they were pitched as safe, effective, non-addictive therapy for chronic pain, said Franklin, an expert on workers’ compensation. They turned out to be none of those things but “we all drank the juice” about their efficacy.

Studies suggest there’s no long-term benefit from using opioids to treat chronic pain, said Franklin. Meanwhile, dependency can develop in as little as 30 days; after 90 days, a patient may never come off them again. Franklin recommended opioids be limited to short-term use for acute pain. The rule should be “start slow, go low,” added Dr. Heidi Oetter, registrar at the College of Physicians and Surgeons of BC.

A “small subset” of doctors is invested in promoting opioids because of relationships with drug companies, a conflict of interest that needs to come out in the open, Wallace added. The CMPA can use its leverage to help doctors “reset the meter.”

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 188 (14)
CMAJ
Vol. 188, Issue 14
4 Oct 2016
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Doctors need education on prescribing opioids
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Doctors need education on prescribing opioids
Steve Mertl
CMAJ Oct 2016, 188 (14) 1003; DOI: 10.1503/cmaj.109-5322

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Doctors need education on prescribing opioids
Steve Mertl
CMAJ Oct 2016, 188 (14) 1003; DOI: 10.1503/cmaj.109-5322
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Resignations at Canada’s drug pricing panel raise independence questions
  • Provinces accept federal health funding deal
  • Feds propose $196B health funding deal with few strings attached
Show more News

Similar Articles

Collections

  • Topics
    • Addiction medicine
    • Drugs: adverse reactions
    • Drugs: pain (including opioids)
    • Medical education, residency, internship

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire